A comparison of biologic therapies for psoriasis

@inproceedings{Abramovits2004ACO,
  title={A comparison of biologic therapies for psoriasis},
  author={William Abramovits and Lisa C. Stevenson},
  year={2004}
}
Prevalence and Characteristics of Psoriasis in Romania—First Study in Overall Population
TLDR
The study of the prevalence of psoriasis will allow the estimation of the number of people suffering from this condition at the national level, as well as the development and validation of a questionnaire to estimate the prevalence and the risk factors associated with the disease.
Considerations for assessing the cost of biologic agents in the treatment of psoriasis.
  • S. Rich
  • Medicine
    Journal of managed care pharmacy : JMCP
  • 2004
TLDR
The biologic agents currently used in the treatment of psoriasis offer patients new hope for safe and effective therapy, and comparison of these agents by managed care decision makers requires consideration of characteristics that differentiate the agents.